Global Kidney Stone Management Devices Market - 2022-2029

Global Kidney Stone Management Devices Market - 2022-2029

Market Overview

The global kidney stone management devices market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

Urolithiasis is the most widespread urological illness, characterized by stone production in the kidney, bladder, and urinary tract. Stone formation in the locations mentioned above is mostly caused by decreased urine volume and increased excretion of stone-forming chemicals such as oxalate, calcium, cysteine, urate, phosphate, and xanthine. Kidney stones can be effectively treated due to the availability of modern procedures, accompanying medical technologies and kidney stone management devices.

Market Dynamics

The global kidney stone management devices market growth is driven by the increasing incidence of urolithiasis in the adult population, mostly among the old community. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers that are expected to increase the market growth.

Growing adoption of minimally invasive stone removal procedures is expected to drive market growth.

Surgeons have rapidly adopted minimally invasive surgical (MIS) techniques for a wide range of applications. High adoption of minimally invasive techniques in general surgery and its minimal side effects compared to open surgical procedures are likely to drive the demand for the advanced procedure for kidney stone management in the near future. According to the journal of Advances in Chronic Kidney Diseases, minimally invasive treatments adopted for mainly three stone diseases in the United States market include extracorporeal shock wave lithotripsy, ureteroscopic lithotripsy, and percutaneous nephrolithotomy. Surgeons are using minimally invasive surgical techniques to conduct procedures that were earlier performed as open surgery. These changing market dynamics are propelling the demand for kidney stone management devices. The recurrence and prevalence of kidney stone diseases are increasing globally. There are limited options for adopting effective drugs to treat the disease. Urolithiasis affects an estimated 12% of the world population at some point in their lifetime. Moreover, other diseases such as obesity, diabetes, and high blood pressure may increase the risk for kidney stones.

Side effects related to shock wave lithotripsy are expected to hamper the market growth.

Despite the increasing incidence of stone diseases, certain factors limit the adoption of its treatment. One of the major factors obstructing the market's growth is its side effects, such as bleeding around the kidneys, blockage of urine due to broken stones, infections, and an increase in arterial blood pressure, among others. Moreover, according to the American Journal of Kidney Diseases, shock wave lithotripsy may pose side effects such as a rise in arterial blood pressure, reduction in renal function, and stone recurrence. Together these complications are expected to hinder the market growth during the forecast period.

Industry Analysis

The kidney stone management devices market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain and regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic adversely impacted the kidney stone management sector, resulting in a drop in revenue. The lockdown caused by the pandemic resulted in the sluggish diagnosis rate of kidney stone disease. Many small hospitals and nursing homes were forced to temporarily shut their operations because of the lockdown. This was done to break infection transmission and diversion of healthcare resources to manage COVID-19 patients. According to the Johns Hopkins University Carey Business School 2020, poor supply chain management, limited availability of raw materials, sluggish medical device manufacturing rate, and a slowdown in the economy are major factors hampering the kidney stone treatment devices market.

Segment Analysis/B>

The lithotripters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029) .

Lithotripsy treats kidney stones by sending focused ultrasonic energy or shock waves directly to the stone first located with fluoroscopy or ultrasound. The shock waves break a large stone into smaller stones that will pass through the urinary system. Lithotripsy allows people with certain types of stones in the urinary system to avoid an invasive surgical procedure for stone removal. Moreover, according to the Research Square Article, 2021, Calcium stones were the most common in all countries (up to 91%), with Canada and China having the highest incidence. Except in Egypt and India, oxalate stones were more common than phosphate or mixed phosphate/oxalate stones. Uric acid stones are more common in Egypt, India, Pakistan, Iraq, Poland, and Bulgaria. Cystine stones were found in 1% of the cases. The prevalence of various forms of urinary stones varies by country. Calcium stones are found in every country. Uric acid stones appear to be primarily influenced by climatic conditions, with prevalence higher in nations with desert or tropical climates. Dietary trends can also cause it. Over the years, intracorporeal lithotripsy has become one of the most preferred methods compared to surgical removal of kidney stones. This has largely been due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes.

Geographical Analysis

North America holds the largest market share of the global kidney stone management devices market.

The North American region accounted for the largest market share in 2021. The market growth is due to factors such as the presence of key players, the high prevalence of urolithiasis in the region, and established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers that are expected to increase market growth. The United States has the maximum share in this region due to supportive healthcare policies, a high number of patients, and a developed healthcare market. In the United States, kidney stones send more than 500,000 people to the emergency room each year, as stated by the National Kidney Foundation. As per the statistics, the increasing patient pool and disposable revenue in this country boost the region's market growth.

Competitive Landscape

Major Key players in the kidney stone management devices market are Boston Scientific Corporation, Becton, Dickinson, and Company, Cook Medical, Olympus Corporation, STORZ MEDICAL AG, Richard Wolf, Dornier MedTech GmbH, and WaLumenis, Stryker among others.

Boston Scientific Corporation:

Overview:

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices used in various interventional medical specialties. The company offers its products by businesses such as Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. Moreover, it operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy, Urology, and Pelvic Health businesses. The rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Across 100+ countries, the company delivers care more effectively by reducing costs, increasing efficiencies, and expanding access to care to help more people live longer, healthier lives.

Product Portfolio:

Dakota Nitinol Stone Retrieval Device with OpenSure Handle: A nitinol hybrid grasper basket designed to capture, reposition and remove stones of varying size and complexity all in a single procedure..

The global kidney stone management devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.